Long-term molecular remission with persistence ofBCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL-Reference-Cited by-同舟云学术

Long-term molecular remission with persistence ofBCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL

Published:2013-10-18 Issue:2 Volume:164 Page:299-302
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Riva Giovanni¹,Luppi Mario¹,Lagreca Ivana¹,Barozzi Patrizia¹,Quadrelli Chiara¹,Vallerini Daniela¹,Zanetti Eleonora¹,Basso Sabrina²,Forghieri Fabio¹,Morselli Monica¹,Maccaferri Monica¹,Paolini Ambra¹,Fantuzzi Valeria¹,Messerotti Andrea¹,Maffei Rossana¹,Iacobucci Ilaria³,Martinelli Giovanni³,Marasca Roberto¹,Narni Franco¹,Comoli Patrizia²,Potenza Leonardo¹

Affiliation:

1. Department of Medical and Surgical Sciences; University of Modena and Reggio Emilia; Haematology Unit; AOU Policlinico; Modena Italy

2. Pediatric Haematology/Oncology Unit; Fondazione IRCCS Policlinico San Matteo; Pavia Italy

3. Department of Experimental; Diagnostic and Specialty Medicine; Institute of Haematology “L. e A. Seragnoli”; University of Bologna; Bologna Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12612/fullpdf

Reference10 articles.

1. How I treat older patients with ALL;Gökbuget;Blood,2013

2. Properties of end-stage human T cells defined by CD45RA re-expression;Henson;Current Opinion in Immunology,2012

3. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial;Mahon;Lancet Oncology,2010

4. Increased natural killer cells and decreased CD3(+)CD8(+)CD62L(+) T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib;Ohyashiki;British Journal of Haematology,2012

5. Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment;Riva;Blood,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifaceted nature of natural killer cells: Potential mode of interaction and shaping of stem cells;NK Cells in Cancer Immunotherapy: Successes and Challenges;2023

2. Chemotherapy Effects on Immune System;Cancer Diagnostics and Therapeutics;2022

3. Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation;Frontiers in Immunology;2020-02-25

4. The immune contexture in cancer prognosis and treatment;Nature Reviews Clinical Oncology;2017-07-25

5. Immunological Mechanisms Underneath the Efficacy of Cancer Therapy;Cancer Immunology Research;2016-10-31